Abstract

Both (+)-[18F]flubatine and its enantiomer (−)-[18F]flubatine are radioligands for the neuroimaging of α4β2 nicotinic acetylcholine receptors (nAChRs) by positron emission tomography (PET). In a clinical study in patients with early Alzheimer’s disease, (+)-[18F]flubatine ((+)-[18F]1) was examined regarding its metabolic fate, in particular by identification of degradation products detected in plasma and urine. The investigations included an in vivo study of (+)-flubatine ((+)-1) in pigs and structural elucidation of formed metabolites by LC-MS/MS. Incubations of (+)-1 and (+)-[18F]1 with human liver microsomes were performed to generate in vitro metabolites, as well as radiometabolites, which enabled an assignment of their structures by comparison of LC-MS/MS and radio-HPLC data. Plasma and urine samples taken after administration of (+)-[18F]1 in humans were examined by radio-HPLC and, on the basis of results obtained in vitro and in vivo, formed radiometabolites were identified. In pigs, (+)-1 was monohydroxylated at different sites of the azabicyclic ring system of the molecule. Additionally, one intermediate metabolite underwent glucuronidation, as also demonstrated in vitro. In humans, a fraction of 95.9 ± 1.9% (n = 10) of unchanged tracer remained in plasma, 30 min after injection. However, despite the low metabolic degradation, both radiometabolites formed in humans could be characterized as (i) a product of C-hydroxylation at the azabicyclic ring system, and (ii) a glucuronide conjugate of the precedingly-formed N8-hydroxylated (+)-[18F]1.

Highlights

  • Both enantiomers (+)-[18 F]flubatine ((+)-(1S,5R,6R)-6-(6-[18 F]fluoro-pyridine-3-yl)-8-azabicyclo[3.2.1]octane, (+)-[18 F]1, Figure 1) and (−)-[18 F]flubatine ((−)-[18 F]1) are radioligands for imaging of α4β2 nicotinic acetylcholine receptors in brain by positron emission tomography (PET).Their development starting from the alkaloid (−)-epibatidine [1], originally isolated from the poison dart frog Epipedobates anthonyi, has been widely reported [2,3,4]

  • For the determination of the fraction of unchanged tracer, samples of arterial blood are collected, prepared, and analyzed by high performance liquid chromatography followed by online radioactive

  • This is in accordance with the previously reported NADPH-dependent degradation by HLM and microsomesoffrom humans (HLM) and mice (MLM) [4], while the metabolite pattern originating from pigs was more metabolism pathways in pig

Read more

Summary

Introduction

Both enantiomers (+)-[18 F]flubatine ((+)-(1S,5R,6R)-6-(6-[18 F]fluoro-pyridine-3-yl)-8-azabicyclo[3.2.1]octane, (+)-[18 F]1, Figure 1) and (−)-[18 F]flubatine ((−)-[18 F]1) are radioligands for imaging of α4β2 nicotinic acetylcholine receptors (nAChRs) in brain by positron emission tomography (PET). Their development starting from the alkaloid (−)-epibatidine [1], originally isolated from the poison dart frog Epipedobates anthonyi, has been widely reported [2,3,4]. In human, (−)-[18 F]1 showed a high metabolic stability 22, 464 [9].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.